# Effects of Sacubitril/Valsartan on Exercise Capacity, Natriuretic Peptides and Ventricular Remodeling in Heart Failure

> **NCT04434170** · — · COMPLETED · sponsor: **Centro Cardiologico Monzino** · enrollment: 112 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Sacubitril-Valsartan

## Key facts

- **NCT ID:** NCT04434170
- **Lead sponsor:** Centro Cardiologico Monzino
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-15
- **Primary completion:** 2020-11-30
- **Final completion:** 2021-12-15
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2024-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04434170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04434170, "Effects of Sacubitril/Valsartan on Exercise Capacity, Natriuretic Peptides and Ventricular Remodeling in Heart Failure". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04434170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*